The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility
Lin Lee Wong(Newcastle upon Tyne Hospitals NHS Foundation Trust), D. I. Jones(Indian Institute of Technology Madras), George Mells(Cambridge University Hospitals NHS Foundation Trust), Stephen Rice(Newcastle University), Holly Fisher(Newcastle University), Stuart Kendrick(GlaxoSmithKline (United Kingdom)), Jessica Dyson(Newcastle upon Tyne Hospitals NHS Foundation Trust), Amardeep Khanna(Newcastle upon Tyne Hospitals NHS Foundation Trust), Ye Htun Oo(University Hospitals Birmingham NHS Foundation Trust), Michael A. Heneghan(King's College Hospital NHS Foundation Trust), Deborah Stocken(Cancer Research UK Clinical Trials Unit)
Cited by 80
Related Papers
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Clinical and genetic characteristics of hereditary pancreatitis in Europe
|Clinical Gastroenterology and Hepatology|2004|615
MAIT cells are activated during human viral infections
|Nature Communications|2016|526
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
|Journal of Hepatology|2020|525